BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29934817)

  • 1. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
    Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
    Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher adaptive functioning and lower rate of psychotic comorbidity in married versus unmarried individuals with 22q11.2 deletion syndrome.
    Mosheva M; Eyal S; Weisman O; Gilad R; Fishman Y; Weinberger R; Weizman A; Gothelf D
    Am J Med Genet A; 2018 Nov; 176(11):2365-2374. PubMed ID: 29171699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
    Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
    Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
    Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
    Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.
    Yuen T; Chow EW; Silversides CK; Bassett AS
    Schizophr Res; 2013 Dec; 151(1-3):221-5. PubMed ID: 24262682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental trajectories in 22q11.2 deletion.
    Swillen A; McDonald-McGinn D
    Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):172-81. PubMed ID: 25989227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome.
    Midbari Kufert Y; Nachmani A; Nativ E; Weizman A; Gothelf D
    J Neural Transm (Vienna); 2016 Dec; 123(12):1491-1497. PubMed ID: 27517838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review.
    Buijs PCM; Bassett AS; Boot E
    Am J Med Genet A; 2018 Aug; 176(8):1742-1747. PubMed ID: 29363845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.
    Green T; Gothelf D; Glaser B; Debbane M; Frisch A; Kotler M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1060-1068. PubMed ID: 19797984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.